Skip to content
Abierto
Menu

Award notice, first published as presolicitation

INFLUENZA VIRUS VAC

SPE2DP-25-R-0006

Defense Logistics Agency, DLA Troop Support. Biological Product (except Diagnostic) Manufacturing.

View on SAM.govMarkdown

Awarded

Seqirus USA Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of September 2, 2025.

Egg-Free Influenza Vaccine Solicitation: SPE2DP25R0006

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Seqirus USA Inc.
UEI
N6U7P2B9VHS5
CAGE
530P3
Vendor location
Summit, NJ
Contract
SPE2DP26D0006
Obligated
$0.00, potential $15,969,518
Actions
1 between February 6, 2026 and February 6, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
4610131521!
Match
award number SPE2DP26D0006 equals the contract number; same awarding office SPE2DP (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 30, 2025

    Presolicitation

    Injectable Egg-Free Influenza Vaccine 2026

    Due August 29, 2025 at 3:00 PM EDT. SAM.gov, notice eed86f85f3284e38a3efab083e8e2b0b

  2. September 2, 2025

    Solicitation, originally presolicitation

    Injectable Egg-Free Influenza Vaccine 2026

    Due October 2, 2025 at 3:00 PM EDT. SAM.gov, notice c6caf7f92517447a9e4e433530bfc02a

  3. February 6, 2026

    Award notice

    Awarded to Seqirus USA Inc. for $15,969,518. SAM.gov, notice 7d43aa10e58346efa52da31226ac3c19

Points of contact

Also open from this buyer